(Q40676887)

22 September 2017

title

Immunogenicity and protective efficacy of a formalin-inactivated rotavirus vaccine combined with lipid adjuvants (English)

1 reference

22 September 2017

1 reference

Kari Johansen

1

1 reference

22 September 2017

Ulf Schröder

series ordinal

2

1 reference

22 September 2017

Lennart Svensson

series ordinal

3

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

22 September 2017

1 reference

22 September 2017

volume

21

1 reference

22 September 2017

issue

5-6

1 reference

22 September 2017

page(s)

368-375

1 reference

Phase 1 trial of a candidate rotavirus vaccine (RV3) derived from a human neonate

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Prevention of Rotavirus-Induced Diarrhea in Neonatal Mice Born to Dams Immunized with Empty Capsids of Simian Rotavirus SA-II

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Noninfectious rotavirus (strain RRV) induces an immune response in mice which protects against rotavirus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Active protection against rotavirus infection of mice following intraperitoneal immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Immunologic correlates of protection against rotavirus challenge after intramuscular immunization of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Rotavirus vaccine administered parenterally induces protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Immunization against bovine rotaviral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Stimulation of local immunity and protection in mice by intramuscular immunization with triple- or double-layered rotavirus particles and QS-21

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Effects of different adjuvants on rotavirus antibody responses and protection in mice following intramuscular immunization with inactivated rotavirus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Nasal and parenteral immunizations with diphtheria toxoid using monoglyceride/fatty acid lipid suspensions as adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Identification of an outer capsid glycoprotein of human rotavirus by concanavalin A

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Neutralization of rotavirus and recognition of immunologically important epitopes on VP4 and VP7 by human IgA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Serum IgA immune response to individual rotavirus polypeptides in young children with rotavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Serum antibody responses to individual viral polypeptides in human rotavirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Epidemiology of rotavirus in infants and protection against symptomatic illness afforded by primary infection and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Rotavirus infection in infants as protection against subsequent infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Protection against Rotavirus Disease after Natural Rotavirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Protection of the villus epithelial cells of the small intestine from rotavirus infection does not require immunoglobulin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Protection Studies in Colostrum-Deprived Piglets of a Bovine Rotavirus Vaccine Candidate Using Human Rotavirus Strains for Challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

The role of helper T cell products in mouse B cell differentiation and isotype regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

Host factors associated with protection against rotavirus disease: the skies are clearing

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900617-5

7 January 2021

10.1016/S0264-410X(02)00617-5

Identifiers

DOI

1 reference

22 September 2017

1 reference